Relx (NYSE:RELX) Reaches New 1-Year High – Here’s Why

Shares of Relx Plc (NYSE:RELX) hit a new 52-week high during trading on Wednesday . The stock traded as high as $50.56 and last traded at $50.56, with a volume of 130415 shares traded. The stock had previously closed at $49.86.

Analyst Upgrades and Downgrades

RELX has been the subject of several research analyst reports. StockNews.com initiated coverage on shares of Relx in a research note on Wednesday, October 30th. They set a “hold” rating for the company. Redburn Atlantic began coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock.

Relx Stock Performance

The company’s 50-day simple moving average is $47.25 and its two-hundred day simple moving average is $46.89. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.48 and a quick ratio of 0.42.

Hedge Funds Weigh In On Relx

A number of large investors have recently bought and sold shares of RELX. SVB Wealth LLC purchased a new stake in shares of Relx during the fourth quarter valued at about $334,000. Private Trust Co. NA increased its holdings in Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after buying an additional 199 shares during the period. Whipplewood Advisors LLC acquired a new position in Relx in the 4th quarter worth approximately $74,000. Denali Advisors LLC increased its holdings in Relx by 3.6% in the 4th quarter. Denali Advisors LLC now owns 15,926 shares of the technology company’s stock worth $723,000 after buying an additional 557 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Relx by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 248,626 shares of the technology company’s stock worth $11,293,000 after buying an additional 12,841 shares during the period. Hedge funds and other institutional investors own 15.02% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.